TIVA in Obstetric Anesthesia? Really?

June 6, 2026, 4:45 pm - 6:15 pm
-----------------------------------------
Learning Objectives:
  1. Describe the pharmacologic principles and clinical rationale underlying the use of total intravenous anesthesia (TIVA) for cesarean delivery.
  2. Compare and contrast the potential advantages and disadvantages of TIVA versus traditional neuraxial and general anesthesia techniques in obstetric patients.
  3. Discuss safety considerations, including maternal hemodynamics, neonatal outcomes, and intraoperative awareness risks.
1.Overall Session Evaluation
Strongly Agree
Agree
Somewhat Agree
Disagree
Strongly Disagree
The objectives were clearly stated 
The stated objectives were met 
I acquired new skills and/or knowledge
I was introduced to new perspectives on my current practice
The content was relevant to my learning needs
This session promoted interaction (i.e., Q&A, polling etc.)
2.This session encouraged me to consider changes to my practice
3.Which CanMEDS roles were addressed?
4.Moderator: Dr Allana Munro
Strongly Agree
Agree
Somewhat Agree
Disagree
Strongly Disagree
The moderator was organized and managed the  session well
5.Speaker: Dr Valerie Zaphiratos
Strongly Agree
Agree
Somewhat Agree
Disagree
Strongly Disagree
Communicated clearly and effectively
Was knowledgeable about this topic
Used clear audiovisual aids, which enhanced the presentation
I would attend another presentation by this speaker in the future
6.Overall, how would you rate the quality and effectiveness of the speaker's presentation with 1 being poor and 10 being excellent?
0
5
10
7.Speaker: Dr Ana Sjaus
Strongly Agree
Agree
Somewhat Agree
Disagree
Strongly Disagree
Communicated clearly and effectively
Was knowledgeable about this topic
Used clear audiovisual aids, which enhanced the presentation
I would attend another presentation by this speaker in the future
8.Overall, how would you rate the quality and effectiveness of the speaker's presentation with 1 being poor and 10 being excellent?
0
5
10
9.The session and presenter(s) were balanced and free from commercial bias
10.Please provide any additional comments or suggestions regarding this session, moderator(s), and speaker(s).
Thank you for completing the evaluation!